The EveryLife Foundation for Rare Diseases, along with 100 other rare disease advocacy organizations, has sent a letter to Commissioner Makary of the FDA, calling for an interactive town hall-style meeting series to strengthen engagement between the FDA and patient advocacy groups.
Related Articles
- FDA Rare Disease Roundtable – June 3, 2026
- The EveryLife Foundation submitted a statement to Congress urging lawmakers to support the inclusion of funding for the Rare Disease Innovation Hub
- EveryLife Foundation for Rare Diseases Emboldens Advocates and Urges Congress to Prioritize Patients During 15th Annual Rare Disease Week on Capitol Hill
